Clinical trial
Assessment of Safety, Tolerability, and Pharmacokinetics of Zileuton Injection in Patients With Asthma
NCT00299065 is registered in ClinicalTrials.gov with Critical Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Safety, Tolerability, and Pharmacokinetics of Zileuton Injection in Patients With Asthma
- Lead sponsor
- Critical Therapeutics
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- June 30, 2006
- Enrollment
- 60
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.